ACEA Biosciences, Inc. to be featured in Upcoming Episode of Innovations with Ed Begley, Jr.

Share Article

DMG Productions explores advancements in bioscience research and technology.

News Image

ACEA Biosciences, Inc. (ACEA) announced that they will be featured in an upcoming episode of Innovations with Ed Begley Jr, airing later this year 2014, via Discovery Channel. Dates and show times TBA.

ACEA is a privately owned biotechnology company pioneering in the development and commercialization of high-performance, cutting edge research instrumentation for life sciences.

In this episode, Innovations will go behind-the-scenes to explore ACEA's mission is transform cell analysis by providing innovative products and solutions to the research and drug discovery community.

“Cardiovascular toxicity is consistently a leading cause of drug attrition and withdrawal,” said Dr. Xiao Xu, President and CEO of ACEA. “We are excited to partner with Innovation to demonstrate how our latest innovation (xCELLigence RTCA CardioECR) in conjunction with stem cell technology (human iPS Cardiomyocytes) provides a higher throughput and more predictive approach that can be used earlier in drug development to reduce both cost and risk. Our goal is to align with the FDA CiPA initiative and support the development of safer medicines for patients.”

“ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R & D and health care industries," said Ryann Watkin, producer for the series. "We are really looking forward to providing this information to our viewers."

About ACEA:
Founded in 2002, ACEA Biosciences, Inc. (ACEA) is a privately owned biotechnology company pioneering in the development and commercialization of cutting edge technology and high-performance research instrumentation for life sciences. Researchers are advancing their studies utilizing 1,300+ placed instruments for broad and diverse applications. The technology has been cited in over 600 peer-reviewed publications. ACEA’s xCELLigence® impedance-based, label-free, real time cell analysis system and NovoCyte™ flow cytometers are used in pre-clinical drug discovery and development, toxicity, safety pharmacology, and basic academic research. For more information, visit: http://www.aceabio.com.

About Innovations and DMG Productions:
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Featuring practical solutions and important issues facing consumers and professionals alike, Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.

DMG Productions (responsible for creating the Innovations show) includes personnel specialized in various fields from agriculture to medicine, independent films to regional news and more. Our field producers work closely with experts in the field to develop stories. This powerful force enables us to consistently produce commercial-free, educational programming that both viewers and networks depend on.

For more information visit: http://www.InnovationsTelevision.com. You can also contact Ryann Watkin at (866) 496-4065 x 813 or via email at: Ryann(at)InnovationsTelevision(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ryann Watkin
DMG Productions
+1 866-496-4065 Ext: 802
Email >
Visit website